Donate to Science & Enterprise

S&E on Mastodon

S&E on LinkedIn

S&E on Flipboard

Please share Science & Enterprise

Primate Genome A.I. Model IDs Human Disease Variants

Mandrill, a primate species

A genomic systems company created an artificial intelligence algorithm from primate genomic data that identifies possible disease-causing mutations in humans. . . . → Read More: Primate Genome A.I. Model IDs Human Disease Variants

Trial Underway Testing Psychedelic Drug for Depression

Sonoran desert toad

The first participant in a clinical trial received a dose of a psychedelic therapy, assessing the experimental compound in people with treatment resistant depression. . . . → Read More: Trial Underway Testing Psychedelic Drug for Depression

Venture Capital Group to Boost Climate Actions

Three wind energy turbines

A venture investor coalition in the U.S. and Europe announced plans to reach net zero emissions by 2030 and help start-up companies quickly achieve their zero emissions goals. . . . → Read More: Venture Capital Group to Boost Climate Actions

Biotechs Partner to Boost mRNA Manufacturing

DNA chip graphic

Two companies working in synthetic biology are advancing a new process they say increases the scale and reduces costs of messenger RNA manufacturing. . . . → Read More: Biotechs Partner to Boost mRNA Manufacturing

HPV Vaccine Generates Immune Responses in Trial

T-cell lymphocyte

Early results from a clinical trial show a vaccine for the human papillomavirus is safe and invokes immune responses in women with low-grade cervical lesions. . . . → Read More: HPV Vaccine Generates Immune Responses in Trial

Business-Academic Team to Create RNA Delivery for Cancer

Vials and bottles

A university lab and biotechnology company are developing new cancer treatments with therapies that stop RNA activity, delivered by advanced nanoscale particles. . . . → Read More: Business-Academic Team to Create RNA Delivery for Cancer

Bio-Electric Regeneration Company Adds $8M in Seed Funds

African clawed frog

A start-up enterprise, spun-off from Tufts University labs, creating bio-electrical treatments for regenerating limbs and tissue, is raising $8 million in new seed funds. . . . → Read More: Bio-Electric Regeneration Company Adds $8M in Seed Funds

Nasal Spray Reduces Flu Duration in Challenge Trial

3-D print of influenza virus

An influenza vaccine given as a nasal spray is shown in a clinical trial to reduce the amount of time participants have flu infections, when exposed to the virus. . . . → Read More: Nasal Spray Reduces Flu Duration in Challenge Trial

Trial Underway Testing Bioelectronic Incontinence Device

neurons

The first participants are enrolled in a clinical trial of an implanted bio-feedback device to help women control urinary incontinence, sudden or stress-related urges to urinate. . . . → Read More: Trial Underway Testing Bioelectronic Incontinence Device

Project to Sequence 20K Dog and Cat Genomes

Dog's nose

Some 20,000 dogs and cats are expected to have their genomes sequenced in the next 10 years for a publicly available database to enable precision medicine for pets. . . . → Read More: Project to Sequence 20K Dog and Cat Genomes